genome analysis as a knowledge tool from which to derive the search for a state of global well-being, not only as a response to suspected pathology
personalized genomics is for achieve perfect physical and mental well-being, not only to diagnose or prevent diseases
everyone has the freedom to choose to analyze and know their own genome
the genomic data belong to the individual and to him alone
are located
in Europe (in Italy, Denmark and Germany), for the European market,
and in the United States (Maryland and California), for the
international market
use the most advanced
technological platforms of
next generation sequencing (NGS) and GSA microarrays and process thousands of samples every year
are ISO 9001, ISO 13485 and
ISO 27001 certified
nico innovagroup
innovabiohealth
innovagenome
filed by the
parent company
nico innovagroup
founders & team
Created with Mobirise - Check this